Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient ...

Palatin Technologies Inc (PTNT) reports significant progress in clinical trials and cost reductions, despite facing financial ...

Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...

2-Year U.S. Treasury Note Continuous Contract $103.207-0.082-0.08% 5-Year U.S. Treasury Note Continuous Contract $107.281-0.211-0.20% 10-Year U.S. Treasury Note Continuous Contract $109.688-0.281 ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Deal follows a settlement in March with current and former Latino, Indigenous and Pacific Islander employees. ‘I was crying and asking God to help me’: San Jose woman held at gunpoint by cops sues ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...